Sales & Earnings In Brief

Plan B lifts women's health for Teva: Second-quarter sales of the emergency contraceptive help drive a 3.9 percent increase in Teva Pharmaceuticals' women's health business to $80 million. Teva is in the midst of de-stocking Plan B inventory as Plan B One-Step -- a single-pill version of the two-pill original product -- becomes available in August, the Jerusalem-based firm said July 28 (1"The Tan Sheet" July 20, 2009). During a same-day earnings call, President and CEO Shlomo Yanai said the women's health business "has outstanding prospects for growth" and Teva intends to expand its oral contraceptive offerings

More from Archive

More from Pink Sheet